Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | DVL3 |
| Upstream (Parents) |
|---|
| (<<) ACTG1 → DVL3 |
| (<<) ACTN1 → DVL3 |
| (<<) ATN1 → DVL3 |
| (<<) ATP2B4 → DVL3 |
| (<<) BCL6 → DVL3 |
| (<<) CASP4 → DVL3 |
| (<<) CFL1 → DVL3 |
| (<<) CYB5R3 → DVL3 |
| (<<) HDAC6 → DVL3 |
| (<<) HGS → DVL3 |
| (<<) MOBKL2C → DVL3 |
| (<<) MSN → DVL3 |
| (<<) NCOR2 → DVL3 |
| (<<) NOTCH2 → DVL3 |
| (<<) PKM2 → DVL3 |
| (<<) PRKCI → DVL3 |
| (<<) SF3A2 → DVL3 |
| (<<) TUBA1B → DVL3 |
| (<<) TUBA1C → DVL3 |
| (<<) TUBB2C → DVL3 |
| Downstream (Children) |
|---|
| DVL3 → CASP3 (>>) |
| DVL3 → EPHB3 (>>) |
| DVL3 → HSPA4 (>>) |
| DVL3 → LOC284542 (>>) |
| DVL3 → MEX3D (>>) |
| DVL3 → MTMR6 (>>) |
| DVL3 → MYH14 (>>) |
| DVL3 → NAV2 (>>) |
| DVL3 → NFATC4 (>>) |
| DVL3 → NFIX (>>) |
| DVL3 → PAK2 (>>) |
| DVL3 → PRNP (>>) |
| DVL3 → SCARB1 (>>) |
| DVL3 → SLC16A6 (>>) |
| DVL3 → TMCC3 (>>) |
| DVL3 → TMEM154 (>>) |
